Variables | Disease free survival | Cancer specific survival | Overall survival | ||||||
---|---|---|---|---|---|---|---|---|---|
HR | 95 % CI | P | HR | 95 % CI | P | HR | 95 % CI | P | |
Gender [male versus female] | 1.213 | 0.59ā2.48 | 0.596 | 1.152 | 0.67ā1.96 | 0.602 | 1.063 | 0.70ā1.60 | 0.770 |
Age [ā¤66 versus >66Ā years] | 1.709 | 0.82ā3.55 | 0.151 | 1.153 | 0.68ā1.94 | 0.592 | 1.191 | 0.79ā1.77 | 0.390 |
Smoking status [never versus current/former] | 1.478 | 0.60ā1.47 | 0.395 | 1.782 | 0.85 - 3.69 | 0.121 | 1.332 | 0.79ā2.23 | 0.278 |
Comorbidity [no versus yes] | 1.395 | 0.65ā2.96 | 0.388 | - | - | - | - | - | - |
ALK-CNGa [Disomic/3-7 versusā>ā7] | 1.695 | 0.49ā5.77 | 0.399 | 1.498 | 0.62ā3.57 | 0.363 | 1.598 | 0.85ā2.98 | 0.141 |
Disease stage [I-II versus III] | 13.12 | 4.59ā37.4 | <0.001 | - | - | - | - | - | - |
T descriptor [1ā2 versus 3ā4] | 3.920 | 1.73ā8.86 | 0.001 | - | - | - | - | - | - |
N descriptor [0 versus 1] | 4.259 | 1.79ā10.2 | 0.001 | - | - | - | - | - | - |
Grading [1 versus 2 versus 3] | 2.128 3.390 | 0.42ā10.6 0.73ā15.6 | 0.357 0.117 | - | - | - | - | - | - |
Surgery [yes versus no] | 8.425 | 3.65ā19.3 | <0.001 | - | - | - | - | - | - |
Performance Status [0 versus 1 versus 2ā3] | - | - | - | 2.358 4.581 | 1.25ā4.42 1.81ā11.5 | 0.007 0.001 | 1.647 3.864 | 1.00ā2.70 1.98ā7.52 | 0.049 <0.001 |
Synchronous Metastases [no versus yes] | - | - | - | 1.119 | 0.15ā8.14 | 0.912 | 2.335 | 1.52ā3.58 | <0.001 |
Response rate to 1st line [yes versus no] | - | - | - | - | - | - | 2.356 | 1.31ā4.23 | 0.004 |